NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Impact of cryopreservation on serum concentration of matrix metalloproteinases (MMP)-7, TIMP-1, vascular growth factors (VEGF) and VEGF-R2 in Biobank samples.

Author(s): Kisand K, Kerna I, Kumm J, Jonsson H, Tamm A

Publication: Clin Chem Lab Med, 2011, Vol. 49, Page 229-35

PubMed ID: 21118050 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of freeze-thaw cycling and storage temperature and duration on the stability of matrix metalloproteinases-7 (MMP-7), MMP-7 tissue inhibitors (TIMP-1), vascular endothelial growth factor (VEGF), and vascular endothelial growth factor receptor 2 (VEGF-R2) in serum.

Conclusion of Paper

TIMP-1 was relatively stable through freeze-thaw cycling and serum MMP-7 and VEGF-R2 remained stable through one freeze-thaw cycle, but three or more cycles significantly increased MMP-7 and VEGF-R2 levels. In contrast, VEGF was the least stable and decreased significantly after just one freeze-thaw cycle. MMP-7 and VEGF-R2 were relatively stable at 4 degrees C, but higher storage temperatures significantly decreased their stability. VEGF and TIMP-1 were unstable at 4 degrees C, and their instability increased with higher storage temperatures.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of freeze-thaw cycling and storage temperature and duration on the stability of MMP-7, TIMP-1, VEGF, and VEGF-R2 in serum. Pooled serum was used for the storage temperature analysis while individual specimens were used for the freeze-thaw cycling analysis. After indicated storage treatment, all specimens were stored at -75 degrees C until analysis.

    Summary of Findings:

    Serum MMP-7 and VEGF-R2 remained stable through one freeze-thaw cycle, but three or more cycles increased MMP-7 levels by 24% and VEGF-R2 levels by 20%. TIMP-1 decreased by less than 13%, even after 6 freeze-thaw cycles, compared to levels in fresh serum. Serum VEGF concentrations decreased by an average of 67% after just one freeze-thaw cycle. MMP-7 was stable in serum stored for up to 35 days at 4 degrees C, but higher storage temperatures significantly decreased MMP-7 stability when compared to concentrations in serum stored at -75 degrees C. Similarly, VEGF-R2 concentrations decreased by only 12% after serum was stored for 35 days at 4 degrees C, while 21 days of storage at 40 degrees C decreased VEGF-R2 levels by 77%. VEGF and TIMP-1 were unstable at 4 degrees C, and their instability increased with higher storage temperatures. The authors extrapolate the stability of these proteins at -20 degrees C and -75 degrees C using the Arrhenius calculation.

    Biospecimens
    Preservative Types
    • Frozen
    • None (Fresh)
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Protein ELISA
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage temperature -75 degrees C
    4 degrees C
    20 degrees C
    30 degrees C
    40 degrees C
    Storage Storage duration 0 d
    7 d
    14 d
    21 d
    35 d
    Storage Freeze/thaw cycling 0 cycles
    1 cycle
    3 cycles
    6 cycles
    Biospecimen Preservation Type of fixation/preservation Frozen
    None (fresh)

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...